menu ☰
menu ˟

Europe Union conditionally approves Merck’s Ebola vaccine, Ervebo

11 Nov 2019
The European Commission granted conditional approval to Ervebo, Merck’s investigational Ebola virus vaccine, which has been used widely and effectively in the ongoing Ebola outbreak in the Democratic Republic of the Congo, or DRC.According to Merck...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.